- Supported exchanges /
- AU /
- PEB.AU
Pacific Edge Ltd (PEB AU) stock market data APIs
Pacific Edge Limited, a cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect, which enables the risk stratification of patients with haematuria; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Pacific Edge Ltd Financial Data Overview
| 0.165 | |
| 0.155 | |
| - | |
| 0.18 | |
| 0.155 | |
| 0.07-0.18 | |
| 134 M | |
| 812 M | |
| 25 229 K | |
| 0 | |
| 0.962 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Pacific Edge Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 25 229 K
- EBITDA -32 829 000
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Pacific Edge Ltd Earnings via APIs
- Latest Release 2024-02-28
- EPS/Forecast 0
Get Pacific Edge Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
